Kissei Pharmaceutical Co. Ltd. 13D and 13G filings for CG Oncology, Inc. Common stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-14 7:25 pm Purchase |
2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON |
Kissei Pharmaceutical Co. Ltd. | 3,543,533 5.300% |
3,543,533 (New Position) |
Filing |